High Point Advisor Group LLC Acadia Pharmaceuticals Inc Transaction History

High Point Advisor Group LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$13.01 - $27.22 $184,221 - $385,435	-14,160 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$15.78 - $24.77 $18,068 - $28,361	-1,145 Reduced 7.48%	14,160 $235,000
Q2 2021 Jul 29, 2021	BUY	$19.4 - $27.42 $10,010 - $14,148	516 Added 3.49%	15,305 $373,000
Q1 2021 Apr 12, 2021	BUY	$25.02 - $54.99 $15,012 - $32,994	600 Added 4.23%	14,789 $302,000
Q4 2020 Feb 10, 2021	BUY	$41.04 - $56.79 $205,938 - $284,972	5,018 Added 54.72%	14,189 $716,000
Q3 2020 Nov 06, 2020	BUY	$36.42 - $57.0 $334,007 - $522,747	9,171 New	9,171 $445,000

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.63B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of High Point Advisor Group LLC, based on Form 13F filings with the SEC.

Stay updated on High Point Advisor Group LLC with notifications on news.